Literature DB >> 3712050

Indium-111 leukocyte imaging in patients with rheumatoid arthritis.

K Uno, N Matsui, K Nohira, T Suguro, Y Kitakata, G Uchiyama, T Miyoshi, S Uematsu, S Inoue, N Arimizu.   

Abstract

This study evaluates the usefulness of labeled leukocyte imaging in patients with rheumatoid arthritis. In 33 patients, the incidence of pain and swelling in 66 wrist joints and 66 knee joints was compared with the accumulation of [111In]leukocytes. No accumulation of [111In]leukocytes was seen in any of the patients' wrists (0/12) or knee joints (0/14) when both pain and swelling were absent. In contrast, 93% (25/27) of wrist joints and 80% (24/30) of knee joints with both pain and swelling were positive by [111In]leukocyte scintigraphy. There was little correlation between the stage of the disease, as determined by radiography, and [111In]leukocyte accumulation. This study suggests that [111In]leukocyte imaging may be a reliable procedure for monitoring the activity of rheumatoid arthritis, especially for confirming the lack of an ongoing inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3712050

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies.

Authors:  W Becker; F Emmrich; G Horneff; G Burmester; F Seiler; A Schwarz; J Kalden; F Wolf
Journal:  Eur J Nucl Med       Date:  1990

2.  Comparison of Indium-111-labeled leukocyte scintigraphy and Technetium-99m joint scintigraphy in rheumatoid arthritis and osteoarthritis.

Authors:  K Uno; T Suguro; K Nohira; H Moriya; K Saegusa; Y Anzai; T Terauchi; K Sato; S Uematsu; N Arimizu
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

3.  Technetium-99m HMPAO labeled leukocytes in inflammation imaging.

Authors:  K Uno; K Yoshikawa; K Imazeki; S Minoshima; N Arimizu
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

4.  Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloids.

Authors:  M Liberatore; M Clemente; A P Iurilli; L Zorzin; M Marini; E Di Rocco; A C Colella
Journal:  Eur J Nucl Med       Date:  1992

Review 5.  New agents for scintigraphy in rheumatoid arthritis.

Authors:  M H de Bois; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1995-11

6.  The complementary role of indium-111 labeled leukocyte imaging, ultrasonography and computed tomography in the evaluation of postoperative infection or abscess.

Authors:  K Uno; K Imazeki; N Arimizu; T Ryu; K Isono; Y Kitakata; H Kohen; S Uematsu
Journal:  Ann Nucl Med       Date:  1987-09       Impact factor: 2.668

7.  Immunoscintigraphic localization of inflammatory lesions: clinical experience.

Authors:  K Seybold; J T Locher; C Coosemans; R Y Andres; P A Schubiger; P Bläuenstein
Journal:  Eur J Nucl Med       Date:  1988

8.  Radiolabelled lymphocyte migration in rheumatoid synovitis.

Authors:  C Jorgensen; I Couret; C Bologna; M Rossi; J Sany
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

9.  Antimicrobial peptides as infection imaging agents: better than radiolabeled antibiotics.

Authors:  Muammad Saeed Akhtar; Muhammad Babar Imran; Muhammad Afzal Nadeem; Abubaker Shahid
Journal:  Int J Pept       Date:  2012-05-17

Review 10.  Insights Into Leukocyte Trafficking in Inflammatory Arthritis - Imaging the Joint.

Authors:  Julia E Manning; Jonathan W Lewis; Lucy-Jayne Marsh; Helen M McGettrick
Journal:  Front Cell Dev Biol       Date:  2021-03-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.